James Metz, MD
Abramson Cancer Center of the University of Pennsylvania
Last Modified: November 1, 2001
|Author: Belleruth Naparstek
Publisher: Warner Books
Price: $11.99 US
Belleruth Naparstek has been a psychotherapist for over twenty-five years and has developed an excellent reference on guided imagery. She has done extensive research with patients, doctors, and nurses to write this manual. She states "guided imagery is a kind of directed daydreaming, a way of using the imagination very specifically to help mind and body heal, stay strong, and even perform as needed." She has also produced numerous audiotapes on directed guided imagery for patients with cancer, receiving chemotherapy, and managing pain or depression.
Staying Well With Guided Imagery is a manual that teaches many techniques in guided imagery. The book begins by explaining guided imagery and how it can work for the reader. It then describes the different kinds of imagery that can be effective for health and well-being. The book includes samples of each type in the form of scripts or narratives. From these scripts, the reader can develop their own personalized journeys that have individualized meaning. There is a section on frequently asked questions on guided imagery. There is also a listing of resources at the end of the book.
This is an excellent introduction on the topic of guided imagery. The book has easy to follow instructions and narratives. It is intended to help the reader improve the quality of their life through directed daydreaming. It is highly recommended by OncoLink.
Dec 7, 2010 - Rituximab may be a better option than watchful waiting in some lymphoma patients, and a new treatment option appears effective for relapsed or refractory Hodgkin's lymphoma, according to two studies being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. Other research being presented will highlight new options for the standard treatment of advanced asymptomatic follicular lymphoma; mantle cell lymphoma; and early, unfavorable Hodgkin's disease.
Mar 17, 2010
Mar 17, 2010